Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
about
A review of sepsis-induced cardiomyopathyNon-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized TrialsVasoactive agents for the treatment of sepsisEffects of Levosimendan on Cellular Metabolic Alterations in Patients with Septic Shock: A Randomized Controlled Pilot Study.Sepsis and Immunosenescence in the Elderly Patient: A Review.Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.Sepsis and Septic Shock: Current Treatment Strategies and New Approaches.[Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].Effect of small-dose levosimendan on mortality rates and organ functions in Chinese elderly patients with sepsis.Cardiac dysfunction in sepsis.[Levosimendan for septic shock with takotsubo cardiomyopathy].Prevention of organ dysfunction in septic shock: still looking for an effective treatment.Life ain't no SOFA-considerations after yet another failed clinical sepsis trial.Effects of dopamine, norepinephrine and dobutamine on gastric mucosal pH of septic shock patients.Effects of levosimendan on mortality in patients with septic shock: systematic review with meta-analysis and trial sequential analysis.Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: A comparative retrospective study.Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature.
P2860
Q26777219-EBE86937-BDE2-4448-BA6A-F7791710C075Q26777564-4BA6FA15-371A-45B2-A3E7-7F62240C73ADQ28068818-EF09851C-6210-4DA6-A466-92385E723682Q30490959-41FE84E4-C4FC-42BC-A9DA-B12574D090F5Q37670488-E6CA8ED2-79C9-4CC5-A3C1-C2E110D03991Q38815453-5D0A119D-2139-44A3-89F5-8EC19C10FE51Q39247164-854146B2-4369-45E9-A363-BBFD72693582Q40147443-34D6A5FA-6430-48A5-8BC8-B7CE2F4387BAQ40176981-AAB4EC0D-C633-48FD-811F-D35479794130Q40568954-B3E1A2E8-419B-4860-876C-C8B64004D088Q40889719-2869D3F0-5A23-4F44-9286-59CE7EFB99BDQ42331443-E98614C5-38F3-49AE-ABEF-B680FD80EE27Q42362371-B3B2DA0D-F414-4374-8E47-AE13E1307899Q42413721-1C8C6B5F-CBA1-45DA-94E3-D46B94EF02F4Q47113590-32E15DC1-A043-4C13-95D7-0D92D48D8A48Q52622851-2DD03A76-793C-43F3-96A2-953074CEBE21Q53833665-F5EF24DF-DC52-4688-BCCD-7D00EEA3C328Q54940493-00C359B1-0C60-4544-9D33-BBF98DBEC3AB
P2860
Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Levosimendan reduces mortality ...... analysis of randomized trials.
@en
type
label
Levosimendan reduces mortality ...... analysis of randomized trials.
@en
prefLabel
Levosimendan reduces mortality ...... analysis of randomized trials.
@en
P2093
P50
P1476
Levosimendan reduces mortality ...... analysis of randomized trials.
@en
P2093
Alessandro Oriani
Elena Bignami
Giovanna Frau
Monica De Luca
Nora Di Tomasso
P304
P356
10.1016/J.JCRC.2015.05.017
P50
P577
2015-05-29T00:00:00Z